Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
22.59
-0.19 (-0.83%)
At close: Sep 18, 2026, 4:00 PM EDT
22.19
-0.40 (-1.77%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.39 billion as of September 18, 2026. Its market cap has increased by 36,843.23% in one year.
Market Cap
1.39B
Enterprise Value
854.09M
1-Year Change
36,843.23%
Ranking
Category
Stock Price
$22.59
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.39B, an increase of 278.17%. That is a compound annual growth rate of 25.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.39B | 3,694.39% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Latigo Biotherapeutics | 1.50B |
| Ultragenyx Pharmaceutical | 1.43B |
| ArriVent BioPharma | 1.42B |
| Alpha Tau Medical | 1.41B |
| Avalyn Pharma | 1.40B |
| Ascentage Pharma Group International | 1.39B |
| First Tracks Biotherapeutics | 1.38B |
| LB Pharmaceuticals | 1.37B |